Literature DB >> 10198191

Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.

K Maruyama1, Y Mori, S Murasawa, H Masaki, N Takahashi, Y Tsutusmi, Y Moriguchi, Y Shibazaki, Y Tanaka, M Shibuya, M Inada, H Matsubara, T Iwasaka.   

Abstract

Vascular endothelial growth factor (VEGF) is not only an endothelial cell-specific angiogenic factor but also a potent mediator of vascular permeability. Interleukin-1 beta (IL-1 beta) is a pro-inflammatory cytokine that has numerous effects on the pathogenesis of the tissue injury. To explore the possible regulation of the VEGF system by IL-1 beta in the heart, we examined the regulation of expression of VEGF and KDR/flk-1 (one of the VEGF receptors) by IL-1 beta using cardiac myocytes and cardiac microvascular endothelial cells (CMEC). Both cardiac myocytes and CMEC substantially expressed VEGF mRNA and its expression was increased 3.6- and 2.4-fold by IL-1 beta, respectively. IL-1 beta-induced accumulations of VEGF mRNA in cardiac myocytes were abolished by the tyrosine kinase inhibitor genistein, whereas inhibition of protein kinase C (PKC) by staurosporin, calphostin C and phorbol ester-induced PKC depletion, and intracellular Ca2+ chelators did not affect the induction of VEGF mRNA by IL-1 beta. Relatively smaller amounts of KDR/flk-1 mRNA were detected in CMEC, but not in cardiac myocytes, and the analysis using quantitative reverse transcription-polymerase chain reaction revealed that IL-1 beta significantly stimulated the accumulation of KDR/flk-1 mRNA 3.0-fold. VEGF protein (23 kDa) levels in Western blot analysis were increased 4.2- and 3.4-fold by IL-1 beta in cardiac myocytes and CMEC, respectively. KDR/flk-1 protein (230 kDa) levels in CMEC were also increased 3.2-fold by IL-1 beta. In addition, pre-treatment of CMEC by IL-1 beta markedly enhanced VEGF-induced tyrosine phosphorylation of focal adhesion kinase compared with that in the unstimulated cells. These findings indicate that cardiac VEGF-KDR/flk-1 system is upregulated by IL-1 beta via activation of tyrosine kinases, suggesting that the IL-1 beta-modulated autocrine and/or paracrine system of VEGF has an important role in the process of angiogenesis in ischemic hearts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198191     DOI: 10.1006/jmcc.1998.0895

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  24 in total

Review 1.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

2.  Multiplexed digital quantification of binge-like alcohol-mediated alterations in maternal uterine angiogenic mRNA transcriptome.

Authors:  Jayanth Ramadoss; Ronald R Magness
Journal:  Physiol Genomics       Date:  2012-04-24       Impact factor: 3.107

Review 3.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

Review 4.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

5.  Angiogenic potency of bone marrow stromal cells improved by ex vivo hypoxia prestimulation.

Authors:  Xiaobo Mao; Qiutang Zeng; Xiang Wang; Linsheng Cao; Zhifeng Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.

Authors:  Yasuhiro Izumiya; Ichiro Shiojima; Kaori Sato; Douglas B Sawyer; Wilson S Colucci; Kenneth Walsh
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

Review 7.  The Impact of Pazopanib on the Cardiovascular System.

Authors:  Cody N Justice; Mohamed H Derbala; Tesla M Baich; Amber N Kempton; Aaron S Guo; Thai H Ho; Sakima A Smith
Journal:  J Cardiovasc Pharmacol Ther       Date:  2018-04-29       Impact factor: 2.457

8.  Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.

Authors:  Christina L Roland; Kristi D Lynn; Jason E Toombs; Sean P Dineen; D Gomika Udugamasooriya; Rolf A Brekken
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

9.  Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Robert S Smith; Yuying Liu; Lin Gao; Lee Chao; Julie Chao
Journal:  Cardiovasc Res       Date:  2008-08-09       Impact factor: 10.787

10.  Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries.

Authors:  Francesco De Francesco; Virginia Tirino; Vincenzo Desiderio; Giuseppe Ferraro; Francesco D'Andrea; Mariateresa Giuliano; Guido Libondi; Giuseppe Pirozzi; Alfredo De Rosa; Gianpaolo Papaccio
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.